Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Algorithm-guided eye refraction for children aged 6–12

Official title: Algorithm-assisted Subjective Refraction Program Dedicated to Children

Run by Essilor International · NCT07046065 · Data updated 2026-11-12

This project tests whether an algorithm-guided subjective refraction program (two versions) can give accurate non-cycloplegic eyeglass prescriptions for children 6–12 compared with the usual manual subjective refraction.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment166 (estimated)
SponsorEssilor International
Industry-sponsored
Locations1 site (Vila Nova de Famalicão)
StatusRecruiting
StartedMay 23, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedJuly 1, 2025
Trial IDNCT07046065 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 who can recognize Latin letters, have pupillary distance ≥49 mm, spherical equivalent between −6.00 and +6.00 D with cylinder ≤3.00 D, and monocular distance visual acuity of at least 0.5 decimal in each eye are ideal candidates.

Probably not a fit

Children with amblyopia, strabismus, prior ocular surgery, ocular or systemic conditions that affect refraction, pupillary distance under 49 mm, or refractive errors outside the study limits are unlikely to benefit from the software in this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The investigation compares two versions of Essilor's Kids Refraction software (vA, which runs the refraction sequence, and vB, which adds steps to manage a child's attention) used with Vision-R™700 or Vision-S™700 phoropters against a conventional manual subjective refraction with the Vision-R™700. The study is non-cycloplegic and measures agreement in sphere, cylinder, axis, and visual acuity between the algorithm-assisted and conventional methods. Phase A validates vA and Phase B validates vB, with randomization to Vision-R or Vision-S devices for the software arms. Participants are children aged 6–12 who can name Latin letters and meet refractive and acuity limits.

Why it matters

Potential benefit: If successful, the software could provide faster, more consistent pediatric refractions and reduce variability between examiners.

How similar studies have gone: Automated and algorithm-based refraction systems have shown reasonable agreement with manual refraction in adults, but dedicated algorithm-assisted subjective refraction specifically designed for children is less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 6 and 12 years
2. Subject able to recognize and name the letters of the Latin alphabet
3. Pupillary distance (PD) not less than 49mm
4. Distance refractive error for spherical equivalence (SE) within the range of \[-6.00 to +6.00 D\] maximum of the two absolute values RE and LE; Cyl ≤ 3.00 D
5. Monocular Visual acuity ≥ +0.30 LogMAR (0.5 Decimal VA) in each eye at distance
6. Visual acuity difference \< 0.20 logMAR between right and left eyes at distance

Exclusion Criteria:

1. Vulnerability of the subject
2. Amblyopia
3. Strabismus
4. Any current or evolving pathology manifested in the eye or the appendages which might have an influence on vision, or interfere with refractive state
5. Any previous ocular surgery, which might have an influence on vision or interfere with study assessments (e.g. iridectomy, refractive surgery…)
6. Any ocular or systemic condition known to affect refractive status (e.g., keratoconus, diabetes, Down's syndrome, etc.)
7. Any neurological or speech disorders that might interfere with the ability to understand and answer questions or communicate with the ECP
8. Any untreated and/or uncontrolled systemic condition which might have an influence on vision or interfere with study assessments
9. Current use of ocular or systemic medications, which, in the Investigator's opinion, may significantly affect pupil size, accommodation or refractive state
10. History of myopia control intervention that may affect refractive assessment (e.g., atropine, orthokeratology, rigid gas permeable lenses (RGP) etc.) except myopia control spectacles
11. Contraindications of cycloplegia (e.g. high Intra-ocular pressure - more than 22mmHg in either eye, narrow anterior angle, history of allergy to cycloplegic agents or seizures, etc)
12. Aphakic or pseudoaphakic (intraocular lens),
13. Prismatic prescription in either Right or Left eye (horizontal or vertical). -

Where it's running

  • Centro de Investigação, Inovação e Ensino Superior (CIIES) de Famalicão
    Vila Nova de Famalicão, Portugal
    Recruiting

Study contacts

  • Principal investigator: José Manuel González- Meijome, PhD — Clinical & Experimental Optometry Research Lab Department of Physics (Optometry) - School of Science University of Minho, 4710-057 Gualtar - Braga (Portugal)
  • Study coordinator: Ana Júlia Sousa
  • Email: asousa@evidenze.com
  • Phone: +351 21 409 60 79

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.